Log in to your Inderes Free account to see all free content on this page.

MedCap

534.00 SEK

-1.11 %

Less than 1K followers

MCAP

NASDAQ Stockholm

Investment

Financials

Overview

Financials & Estimates

Ownership

Investor consensus

-1.11 %

-8.09 %

-11.88 %

+21.09 %

-11.15 %

-9.03 %

+153.08 %

+134.21 %

+5,187.13 %

MedCap operates in the investment industry and focuses on long-term equity investments in medical technology and pharmaceutical companies. The company's portfolio includes companies in sectors such as biotechnology and medical technology. The operations are primarily concentrated in Sweden, with a primary presence in the Stockholm region. MedCap was founded in 2001 and is headquartered in Stockholm.

Market cap

8.03B SEK

Turnover

5.01M SEK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

6.2.

2026

Annual report '25

29.4.

2026

Interim report Q1'26

21.7.

2026

Interim report Q2'26

All

Press releases

3rd party

ShowingAll content types

Press release10/27/2025, 1:26 PM

Redeye: MedCap (Q3 review) - Healthy Q3 figures

Regulatory press release10/24/2025, 4:30 AM

MedCap AB: Strong organic and acquired growth; EBITA increased by 32%

Regulatory press release10/1/2025, 1:00 PM

MedCap AB: Abilia acquires LivAssured

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Press release7/23/2025, 12:05 PM

Redeye: MedCap Q2 2025 - The rise, fall, and rise again

Regulatory press release7/23/2025, 4:30 AM

MedCap AB: Strong quarter with 20 percent EBITA growth and acquisition in Specialty Pharma

Regulatory press release7/21/2025, 10:00 AM

MedCap AB: MedCap's Business Area Specialty Pharma Completes the Acquisition of XGX Pharma

Regulatory press release6/25/2025, 5:30 AM

MedCap AB: MedCap's Business Area Specialty Pharma Acquires XGX Pharma

Press release4/30/2025, 5:47 AM

Redeye: MedCap Q1 2025 - Step by step

Regulatory press release4/29/2025, 4:30 AM

MedCap AB: 7% growth and EBITA margin recovers to 17%

Press release2/3/2025, 7:53 AM

Redeye: MedCap Q4 2024 - A tale of euphoria and despair

Regulatory press release1/31/2025, 5:30 AM

MedCap AB: Good demand but unsatisfactory earnings. Strong cash flow.

Regulatory press release1/31/2025, 5:30 AM

MedCap AB: MedCap's Business Area Assistive Tech Acquires Danrehab

Regulatory press release1/16/2025, 5:30 PM

MedCap AB: Preliminary result for the fourth quarter

Press release11/4/2024, 9:24 AM

Redeye: Redeye Initiates Coverage of MedCap

Regulatory press release10/25/2024, 4:30 AM

MedCap AB: Profit growth, stronger cash flow and acquisitions

Regulatory press release7/24/2024, 4:30 AM

MedCap AB: Continued strong growth - adjusted EBITA increased by 13 percent

Regulatory press release7/24/2024, 4:30 AM

MedCap AB: Abilia acquires Picomed and Alert-IT

Press release7/12/2024, 8:00 AM

MedCap AB: Changed date for the release of MedCap's half-year report 2024

Regulatory press release5/3/2024, 4:30 AM

MedCap AB: Strong first quarter - EBITA up 46 percent

Press release3/25/2024, 2:45 PM

MedCap AB: Abilia acquires Kompany AS and the product Komp

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.